Nasopharyngeal Neoplasms
2 competing products in clinical development for Nasopharyngeal Neoplasms.
Pipeline by Phase
Phase 22
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| The combination treatment of anlotinib, penpulimab and capecitabine. | Sun Pharmaceutical | Phase 2 | Active | 39 |
| Amifostine every-other-day regimen + Amifostine everyday regimen | Sun Pharmaceutical | Phase 2 | UNKNOWN | 31 |